21.12 0.00 (0.00%)
Pre-Market: 7:59AM EDT
Previous Close | 21.06 |
Open | 21.04 |
Bid | 20.93 x 1000 |
Ask | 0.00 x 1200 |
Day's Range | 20.51 - 21.65 |
52 Week Range | 18.12 - 57.21 |
Volume | 1,397,030 |
Avg. Volume | 1,670,481 |
Market Cap | 1.939B |
Beta (5Y Monthly) | 1.19 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.11 |
Earnings Date | May 04, 2021 - May 10, 2021 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 40.57 |
NEW YORK, NY / ACCESSWIRE / April 23, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.
New Orleans, Louisiana--(Newsfile Corp. - April 22, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 11, 2021 to file lead plaintiff applications in a securities class action lawsuit against FibroGen, Inc. (NASDAQ: FGEN), if they purchased the Company's securities and/or sold put options between November 8, 2019 and April 6, 2021, inclusive (the "Class Period"). ...
RADNOR, PA / ACCESSWIRE / April 22, 2021 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of FibroGen, Inc. (NASDAQ:FGEN) ("FibroGen") that a securities fraud class action lawsuit has been filed against on behalf of those who purchased or acquired FibroGen securities and/or sold put optionsfrom November 8, 2019 through April 6, 2021, inclusive (the "Class Period").